Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind trial of DU-176b vs dalteparin for VTE prevention after total hip replacement
2006-000758-29Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of edoxaban in venous thromboembolism (VTE) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Incidence of confirmed venous thromboembolism (VTE). Started Aug 2006; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2006-000758-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000758-29.